KESTRA MEDICAL TECHNOLOGIES, LTD.
For the period ended Oct 31, 2025. Filed Dec 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 11, 2025
KMTS$28.80+0.9%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| October 31, | April 30, | |
|---|---|---|
| 2025 | 2025 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $175,424 | $237,595 |
| Accounts receivable, net | 10,413 | 8,081 |
| Disposable medical equipment supplies | 6,918 | 6,572 |
| Prepaid expenses and other current assets | 2,659 | 3,080 |
| Total current assets | 195,414 | 255,328 |
| Right-of-use assets | 1,960 | 2,078 |
| Deposits | 1,858 | 2,021 |
| Restricted cash | 334 | 334 |
| Property and equipment, net | 45,932 | 34,830 |
| Other long-term assets | 1,203 | 1,153 |
| Total assets | $246,701 | $295,744 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $20,209 | $23,961 |
| Accrued liabilities | 15,494 | 13,829 |
| Operating lease liabilities, current portion | 53 | 187 |
| Total current liabilities | 35,756 | 37,977 |
| Operating lease liabilities, net of current portion | 2,874 | 3,026 |
| Warrant liabilities | 1,977 | 8,097 |
| Other long-term liabilities | 140 | 140 |
| Long-term debt, net | 41,873 | 41,098 |
| Total liabilities | 82,620 | 90,338 |
| Commitments and contingencies (Note 14) | ||
| Shareholders’ equity | ||
| Common Shares, $1.00 par value; 100,000,000 shares authorized as of October 31, 2025 and April 30, 2025; 51,449,053 issued and outstanding as of October 31, 2025 and 51,348,656 shares issued and outstanding as of April 30, 2025 | 51,449 | 51,349 |
| Additional paid-in capital | 691,492 | 674,306 |
| Accumulated deficit | (578,860) | (520,249) |
| Total shareholders’ equity | 164,081 | 205,406 |
| Total liabilities and shareholders’ equity | $246,701 | $295,744 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.